The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...
Tenpoint plans to submit an FDA new drug application in the first half of 2025. Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase ...
The US contact lenses market is expected to grow at a CAGR of $% from 2022 to 2028 with an increasing number of eye inaccuracies among the younger population.
Building upon its rich history and founder's guiding vision of making today better than yesterday, tomorrow better than today, the OASYS solution brings together two areas of focus: sustainable ...
Further details will be presented at upcoming scientific meetings. “Tenpoint Therapeutics is the only company in the presbyopia category to demonstrate contribution of elements with BRIMOCHOL™ PF, ...